system
evalu
activ
antivir
agent
rauscher
murin
leukemia
viru
rmulv
develop
use
enzym
link
immunosorb
assay
techniqu
activ
variou
antivir
compound
demonstr
assay
system
compar
activ
uvxc
plaqu
reduct
assay
use
histor
evalu
antirmulv
compound
assay
base
upon
detect
rmulv
encod
protein
product
viru
infect
murin
cell
assay
reagent
readili
avail
assay
system
amen
autom
data
collect
system
cytotox
evalu
conduct
parallel
rauscher
mulv
elisa
assay
order
assess
druginduc
reduct
cell
viabil
cytotox
evalu
import
interpret
elisa
result
sinc
reduct
cell
viabil
reduc
viral
protein
product
would
indic
antivir
drug
effect
system
less
sensit
classic
uvxc
plaqu
reduct
assay
howev
offer
altern
timeconsum
laborintens
plaqu
assay
rauscher
murin
leukemia
viru
retroviru
elisa
rauscher
murin
leukemia
viru
rmulv
rauscher
infect
mice
use
model
evalu
anticanc
chirigo
et
al
chirigo
et
al
recent
antihiv
compound
ruprecht
et
al
ruprecht
et
al
gener
vitro
assay
conduct
prior
vivo
evalu
assess
potenti
drug
inhibit
virusinduc
diseas
histor
evalu
perform
use
uvxc
plaqu
reduct
assay
shannon
et
al
assay
system
laborintens
requir
experienc
personnel
quantit
plaqu
format
sever
worker
report
altern
assay
system
measur
mulv
gener
assay
reli
upon
immunofluoresc
et
al
situ
hybrid
rein
et
al
purothionin
cytotox
tahara
et
al
radioimmunoassay
scolnick
et
al
viru
quantit
recent
focu
form
assay
describ
use
immunofluoresc
sitbon
et
al
immunoperoxidas
nexo
label
aid
detect
mulvinduc
foci
system
improv
visual
count
effici
assay
amen
autom
data
collect
analysi
like
newer
elisa
methodolog
proven
thu
establish
assay
system
allow
autom
data
collect
system
similar
concept
assay
system
describ
quantit
antivir
activ
antivir
antibodi
respons
herpesvirus
rabalai
et
al
dengu
fiqueiredo
shope
bovin
viral
diarrhea
justewicz
et
al
coronavirus
smith
winograd
assay
virusinfect
monolay
cultur
serv
antigen
sourc
indirect
elisa
assay
multiwel
cultur
plate
seed
cell
hartley
row
eagl
minimum
essenti
medium
emem
supplement
heatinactiv
fetal
bovin
serum
fb
u
penicillinml
g
streptomycinml
tissu
cultur
medium
follow
overnight
incub
cell
adher
medium
remov
deaedextran
solut
gml
pb
ad
well
follow
incub
min
deaedextran
remov
well
rins
phosphatebuff
salin
pb
serial
dilut
test
compound
prepar
tissu
cultur
medium
x
desir
final
concentr
ad
replic
well
lwell
six
viru
control
well
receiv
tissu
cultur
medium
cell
control
well
receiv
tissu
cultur
medium
viruschalleng
well
test
viru
control
receiv
viral
inoculum
prepar
x
desir
final
concentr
pfuwel
day
incub
medium
aspir
plate
well
rins
pb
cell
fix
cold
ethanol
aceton
min
fix
decant
plate
allow
airdri
overnight
room
temperatur
rt
elisa
assay
well
block
h
rt
fb
prepar
pb
primari
antibodi
consist
dilut
goat
antirausch
antibodi
ncibcb
repositori
ad
well
incub
h
well
rins
time
wash
solut
pb
second
antibodi
affinitypurifi
horseradish
peroxidaselabel
antigoat
igg
tago
immunolog
burlingam
ca
ad
follow
incub
h
well
rins
time
wash
solut
sulfon
substrat
kirkegaard
perri
laboratori
inc
gaithersburg
md
ad
optic
densiti
nm
determin
spectrophotometr
micropl
reader
follow
incub
h
averag
calcul
set
replic
viru
cell
control
percent
reduct
protein
calcul
percent
reduct
plot
inhibitori
concentr
determin
uvxc
plaqu
reduct
assay
describ
previous
shannon
et
al
briefli
tissu
cultur
plate
seed
cell
tissu
cultur
medium
overnight
incub
medium
aspir
well
ml
drug
solut
x
ml
viru
inoculum
ad
replic
well
control
includ
cell
control
tissu
cultur
medium
drug
viru
viru
control
viru
medium
drug
day
postinocul
medium
decant
cultur
irradi
ultraviolet
light
well
receiv
xc
cell
svoboda
day
postirradi
cultur
rins
pb
fix
buffer
formalin
stain
crystal
violet
airdri
plaqu
enumer
aid
dissect
microscop
antivir
activ
express
reduct
mean
number
plaqu
count
drugtreat
virusinfect
cultur
compar
mean
number
plaqu
untreat
virusinfect
control
cultur
drug
concentr
reduc
mean
number
plaqu
calcul
use
regress
analysi
semilog
curv
fit
cytotox
determin
parallel
mtt
assay
perform
well
plate
cytotox
determin
perform
bromid
mtt
dye
reduct
assay
mosmann
cell
monolay
prepar
multiwel
tissu
cultur
plate
parallel
elisa
uvxc
plate
cytotox
assay
perform
parallel
elisa
assay
cell
pretreat
deaedextran
test
compound
ad
well
desir
final
concentr
volum
control
includ
cell
incub
tissu
cultur
medium
alon
cell
control
color
control
contain
cell
receiv
remain
reagent
plate
incub
parallel
elisa
day
uvxc
day
plate
follow
incub
well
receiv
mgml
solut
mtt
prepar
tissu
cultur
medium
incub
sodium
dodecyl
sulfat
sd
n
solut
ad
well
plate
incub
overnight
optic
densiti
nm
determin
spectrophotometr
micropl
reader
averag
calcul
set
replic
percent
cell
control
calcul
drug
dilut
mean
drug
treat
color
control
mean
cell
control
medium
control
x
data
plot
conjunct
percent
reduct
viru
product
minimum
toxic
concentr
defin
concentr
reduc
cell
viabil
less
cell
control
seri
compound
assay
elisa
uvxc
system
icso
mtc
result
compound
present
tabl
result
obtain
two
system
correl
well
although
drug
concentr
requir
suppress
protein
product
measur
elisa
system
gener
higher
requir
suppress
uvxc
plaqu
format
one
compound
diarylsulfon
demonstr
antivir
activ
uvxc
plaqu
reduct
assay
howev
activ
detect
protein
reduct
assay
elisa
compound
inact
viru
yield
reduct
assay
data
shown
thu
elisa
assay
may
indic
activ
compound
case
compound
activ
detect
uvxc
plaqu
reduct
assay
believ
result
cytotox
xc
cell
use
overlay
graphic
present
uvxc
elisa
data
dideoxythymidin
azt
shown
fig
reduct
viru
product
either
percent
plaqu
reduct
percent
reduct
protein
graph
left
yaxi
virusinfect
cell
cytotox
present
percent
cell
control
graph
right
yaxi
toxic
control
cell
data
present
form
readili
interpret
visual
without
need
extens
analysi
numer
valu
assay
posit
control
drug
azt
multipl
time
averag
azt
assay
median
standard
deviat
feel
indic
result
reproduc
assay
assay
primari
differ
theelisa
assay
uvxc
plaqu
reduct
assay
drug
concentr
requir
suppress
viru
product
endpoint
uvxc
plaqu
reduct
assay
measur
capac
antivir
compound
reduc
product
infecti
viru
rat
xc
cell
place
contact
mulvinfect
cell
syncytia
form
xc
cell
overlaid
onto
mulvinfect
cell
monolay
fail
infiltr
cell
sheet
mulvinfect
area
result
lightli
stain
area
plaqu
mulv
infect
cell
kill
exposur
uv
light
still
capabl
induc
syncytia
xc
cell
overlay
grow
die
cell
uniform
monolay
except
mulv
infect
present
area
hole
xc
cell
monolay
contain
multipl
giant
cell
focal
mass
giant
cell
product
syncytia
presum
function
glycoprotein
typifi
retrovirus
ie
gp
hiv
contrast
elisa
system
measur
capac
compound
reduc
product
viru
protein
form
part
virion
core
similar
protein
hiv
protein
encod
viral
nucleic
acid
reduct
protein
product
occur
compound
interfer
translat
viral
nucleic
acid
thu
compound
interfer
viru
attach
penetr
integr
transcript
translat
reduc
protein
product
compound
interfer
late
stage
viru
product
cycl
ie
viru
bud
would
necessarili
reduc
protein
level
case
elisa
assay
give
result
compat
found
uvxc
assay
assay
compound
toxic
effect
xc
cell
assay
compound
activ
late
viru
replic
cycl
act
interf
infect
progeni
viru
protein
produc
progeni
viru
unabl
infect
new
target
system
describ
sensit
antivir
drug
uvxc
plaqu
reduct
assay
offer
altern
method
antivir
drug
evalu
found
compound
produc
toxic
xc
cell
overlay
could
evalu
test
system
also
smaller
quantiti
compound
requir
elisa
sinc
perform
plate
rather
plate
use
uvxc
plaqu
reduct
assay
use
system
evalu
analog
known
posit
compound
select
optim
drug
vivo
test
system
modifi
variou
step
includ
increas
viru
replic
phase
ie
incub
alter
viru
inoculum
dose
alter
elisa
reagent
concentr
incub
time
collect
supernat
yield
reduct
assay
thu
system
adjust
meet
desir
goal
